Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Opening SoonPAR-26-091

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

National Institutes of Health opportunity PAR-26-091

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthPAR-26-091Grants.gov
Related Grants
HealthUpcoming
Notice of Funding Opportunity (NOFO) SUSI Civic Engagement and Environmental Issues Selection Process
Varies
Health● Open
Fundamental Research to Counter Weapons of Mass Destruction
Varies
30 Sep 2034(2920d)
Health● Open
DoW Spinal Cord Injury, Clinical Translation Research Award
Varies
12 Nov 2026(41d)
HealthUpcoming
Assessing the Feasibility of Incorporating Mechanisms in Multisite Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration
Varies
Funding Amount
Varies
USD
Apply Now
Programme Details
Programme Code
PAR-26-091